10 drugs costing Medicare Part D the most

Alia Paavola - Print  | 

Medicare covered 30 percent of prescription drug costs, or $101 billion, in 2017, according to a new Kaiser Family Foundation study.

The 10 drugs costing Medicare the most:

1. Harvoni ($4.4 billion)
2. Revlimid ($2.6 billion)
3. Lantus Solostar ($2.5 billion)
4. Januvia ($2.4 billion)
5. Crestor ($2.3 billion)
6. Advair Diskus ($2.3 billion)
7. Lyrica ($2.1 billion)
8. Xarelto ($1.9 billion)
9. Eliquis ($1.9 billon)
10. Spiriva ($1.8 billion)

More articles on pharmacy:
How hospitals can better align the pharmacy to achieve its strategic goals
Google sister-company Verily partners with big pharma for clinical trials
Merck's Keytruda fails late-stage trial as standalone treatment for breast cancer

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

To receive the latest hospital and health system business and legal news and analysis from Becker's Hospital Review, sign-up for the free Becker's Hospital Review E-weekly by clicking here.